Company intelligence / Profile preview

Hangzhou Weiqiang Medical Technology

Hangzhou, Zhejiang, Chinacrunchbase.com ↗

Ownership: Private
Development stage: Other

Overview

Hangzhou Weiqiang has completed at least one multicenter clinical trial evaluating the safety and efficacy of a steerable catheter for vascular interventional access, with positive results supporting its use in establishing vascular intervention access during surgery or angiography diagnosis. The Grency® Iliac Vein Stent System received NMPA approval in 2025 for commercial use in China to treat non-thrombotic iliac vein compression syndrome.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Hangzhou Weiqiang Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hangzhou Weiqiang Medical Technology.

Explore the full profile